EUVIMEDEUVIMED entdecken
Open Access

CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma

Jixing Zhao, Xiaoteng Cui, Qi Zhan, Kailiang Zhang, Dongyuan Su, Shixue Yang, Biao Hong, Qixue Wang, Jiasheng Ju, Chunchao Cheng, Chen Li, Chunxiao Wan und 3 weitere

Theranostics · 2024

DOI: 10.7150/thno.92703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Jixing Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory…. Hauptthemen laut MEDLINE: Glioblastoma, Temozolomide, Drug Resistance, Neoplasm, CRISPR-Cas Systems. Die Arbeit wurde bisher 45-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTemozolomideDrug Resistance, NeoplasmCRISPR-Cas SystemsExosomesHumansCell Line, TumorAnimalsMiceBrain NeoplasmsCarcinogenesisMice, NudeXenograft Model Antitumor Assays

Stichwörter der Autor:innen

CRISPR/Cas9ERBINRASGRP1VPS28glioblastoma

Substanzen

Temozolomide

Autor:innen und Institutionen

  • Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous…
  • Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, 250012, China.
  • Department of Physical Medicine and Rehabilitation, Tianjin Medical University General Hospital, Tianjin, China.

Zitieren

APA

Zhao, J., Cui, X., Zhan, Q., Zhang, K., Su, D., Yang, S., Hong, B., Wang, Q., Ju, J., Cheng, C., Li, C., Wan, C., Wang, Y., Zhou, J., & Kang, C. (2024). CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma. Theranostics. https://doi.org/10.7150/thno.92703

Vancouver

Zhao J, Cui X, Zhan Q, Zhang K, Su D, Yang S, et al. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma. Theranostics. 2024. doi:10.7150/thno.92703

BibTeX
@article{Zhao2024,
  author = {Zhao, Jixing and Cui, Xiaoteng and Zhan, Qi and Zhang, Kailiang and Su, Dongyuan and Yang, Shixue and Hong, Biao and Wang, Qixue and Ju, Jiasheng and Cheng, Chunchao and Li, Chen and Wan, Chunxiao and Wang, Yunfei and Zhou, Junhu and Kang, Chunsheng},
  title = {CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma},
  journal = {Theranostics},
  year = {2024},
  doi = {10.7150/thno.92703}
}
Kostenlos starten →